Diseases, Conditions, Syndromes

Malaria: Cooperating antibodies enhance immune response

Malaria is one of the most infectious diseases worldwide. Scientists from the German Cancer Research Center (DKFZ) in Heidelberg, Germany, and from the Hospital for Sick Children (SickKids) in Toronto, Canada, have studied ...

Diseases, Conditions, Syndromes

Why Kenya isn't winning the war against malaria in some counties

In the past 15 years the Kenyan government has made great strides in preventing and controlling malaria. It has issued insecticide treated bed nets, sprayed people's homes with insecticides and ensured that there is widespread ...

Diseases, Conditions, Syndromes

Human antibodies undermine parasite sex

Some people develop an immune response following a malaria infection that stops them from infecting other mosquitoes. The antibodies that these people produce are ingested by the mosquito and destroy the malaria parasite ...

Diseases, Conditions, Syndromes

PATH and WRAIR announce largest-ever controlled malaria infection

PATH's Malaria Vaccine Initiative (MVI) and the US Department of Defense's Walter Reed Army Institute of Research (WRAIR) announced today that vaccinations are under way in a clinical trial to evaluate modifications to the ...

Diseases, Conditions, Syndromes

Modified experimental vaccine protects monkeys from deadly malaria

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight ...

Medical research

Experimental vaccine protects against multiple malaria strains

An experimental malaria vaccine protected healthy subjects from infection with a malaria strain different from that contained in the vaccine, according to a study published today in the Proceedings of the National Academy ...

Medical research

Scientists devise novel way to predict efficacy of malaria vaccines

The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, ...

page 9 from 15